Neurothera Labs Inc (NTLX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 01-2025 | 01-2024 | 01-2023 | 01-2022 | 01-2021 | |
| Operating Expenses | 255 | 105 | 80 | 150 | 5 |
| Operating Income | -255 | -105 | -80 | -150 | -5 |
| Other Income | 0 | 0 | 0 | -3 | 0 |
| Pre-tax Income | -255 | -105 | -80 | -153 | -5 |
| Net Income Continuous | -255 | -105 | -80 | -153 | -5 |
| Net Income | $-255 | $-105 | $-80 | $-153 | $-5 |
| EPS Basic Total Ops | -0.01 | -0.01 | 0.00 | -0.03 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | 0.00 | -0.03 | N/A |
| EPS Diluted Total Ops | -0.01 | -0.01 | 0.00 | -0.03 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | 0.00 | -0.03 | N/A |
| EBITDA(a) | $-255 | $-105 | $-80 | $-150 | $-5 |